Pharmacies - Switzerland | Statista Market Forecast

The revenue in the Pharmacies market in Switzerland is forecasted to reach CHF US$9.16bn in 2024.
It is expected to experience an annual growth rate (CAGR 2024-2029) of 3.13%, leading to a market volume of CHF US$10.69bn by 2029.
In comparison to other countries, United States is projected to generate the highest revenue in the Pharmacies market, with CHF US$387.30bn in 2024.
When considering the total population, in Switzerland is estimated to generate CHF US$1.03k per person in revenue in the Pharmacies market in 2024.
Switzerland's pharmacies are thriving due to the country's high healthcare standards and demand for quality pharmaceutical products.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in Switzerland has been experiencing steady growth in recent years.

Customer preferences: Swiss customers have a strong preference for high-quality and reliable healthcare products. They value personalized service and expert advice when it comes to their health and well-being. Swiss consumers also prioritize convenience and accessibility, which has led to an increase in online pharmacy services.

Trends in the market: One major trend in the Swiss Pharmacies market is the growing demand for natural and organic healthcare products. Swiss consumers are increasingly concerned about the ingredients and environmental impact of the products they use, leading to a rise in the popularity of natural remedies and organic supplements. Another trend is the increasing popularity of online pharmacies, which offer a wide range of products and the convenience of home delivery. This trend has been further accelerated by the COVID-19 pandemic, as more consumers are opting for online shopping to reduce their exposure to crowded places.

Local special circumstances: Switzerland has a highly regulated healthcare system, which ensures the quality and safety of pharmaceutical products. The country has strict regulations on the sale and distribution of prescription drugs, which can only be obtained from licensed pharmacies. This has created a competitive advantage for traditional brick-and-mortar pharmacies, as they are the only authorized sellers of prescription medication. However, online pharmacies have also gained traction in the Swiss market, offering over-the-counter products and supplements that do not require a prescription.

Underlying macroeconomic factors: Switzerland has a high standard of living and a well-developed healthcare system, which contributes to the growth of the Pharmacies market. The country has a strong economy and a high per capita income, allowing consumers to afford quality healthcare products. Additionally, Switzerland has an aging population, which drives the demand for healthcare products and services. The government also plays a significant role in the healthcare sector, providing universal healthcare coverage and promoting the use of generic drugs to reduce healthcare costs. These factors contribute to the overall growth and stability of the Pharmacies market in Switzerland.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.